Aegerion CEO on Cholesterol Drug Lomitapide

Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug. Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Was the DNC Hack Preventable?
55:57 - Eric O'Neill, Carbon Black's national security strategist, discusses how to respond to government hacks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Will Berlin Become Europe's Top Tech Hub?
  • Full Show: Best of Bloomberg Markets Middle East (07/29)
  • Talend CEO: Why We Decided to Go Public Now